Steep rise in older Britons hospitalised for drug abuse
Number of middle-aged patients suffering drug-related mental disorders has surged by 85% over the past decade

NHS hospitals have seen a massive increase in the number of middle-aged and older people being admitted for drug misuse, according to a new report by the health service.
The latest annual statistics for England reveal that admissions of people aged 45 and above for drug-related mental and behavioural disorders have almost doubled since 2007, from 638 to 1,182, compared with only a 1% increase for those aged under 45. Typical symptoms include “hallucinations, confusion, extreme agitation and disinhibition”, The Guardian reports.
Hospital admissions for poisoning as a result of drug misuse has increased by 32% over the past six years among people aged 55 and above.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
And around one in three drug-related deaths registered in 2017 were of people aged between 40 and 49, higher than any other age group.
Experts have warned that so-called baby boomers are in denial over alcohol and drug abuse, and are less likely to accept they have a problem than younger people, reports The Daily Telegraph.
The Guardian says that the figures have also “prompted experts to claim that controversial changes in the Government’s approach to drug addiction”, which now emphasises abstinence over harm reduction, has led to the rise in admissions.
“It is clear from this data that older people are suffering the consequences of cuts made to drug treatment services over recent years,” said Ian Hamilton, associate professor of addiction at the University of York.
“They are more likely to have had longer drug-using careers, so they will need longer in specialist drug treatment. However, unfortunately, treatment services are being directed to offer abstinence-based services rather than maintaining this group on substitute drugs like methadone.”
Hamilton suggested that naloxone, a medication that can block the effect of opioids following a potentially fatal overdose, should be more readily available, along with “safe injection facilities” where users can inject drugs in a hygienic environment.
Last year there were a total of 2,503 drug-related deaths in England - a slight decrease from 2016 (2,596), but a 38% increase from 2007 (1,809).
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Exploring the three great gardens of Japan
The Week Recommends Beautiful gardens are 'the stuff of Japanese landscape legends'
By The Week UK
-
Is Prince Harry owed protection?
Talking Point The Duke of Sussex claims he has been singled out for 'unjustified and inferior treatment' over decision to withdraw round-the-clock security
By The Week UK
-
Sudoku medium: April 20, 2025
The Week's daily medium sudoku puzzle
By The Week Staff
-
Washwood Heath: Birmingham's pioneering neighbourhood health service
In the Spotlight NHS England chair says there is a 'really good argument this is the model for the future'
By The Week UK
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US
-
The UK's first legal drug consumption room
The Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
By The Week UK
-
How can the UK solve the adult social care crisis?
Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
By Elizabeth Carr-Ellis, The Week UK
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US
-
ADHD drugs shortage: what's behind it?
The Explainer Supply chain issues and 'tripling' of prescriptions concerns GPs as problems getting medication become 'desperate'
By The Week UK
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
By The Week UK
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
By Harriet Marsden, The Week UK